Please use this identifier to cite or link to this item: http://dspace.utpl.edu.ec/handle/20.500.11962/22920
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorAldaz Roldan, Pablo Renatoes_ES
dc.contributor.authorCedeño Cueva, Julio Alejandroes_ES
dc.date.accessioned2018-10-09T15:44:50Z-
dc.date.available2018-10-09T15:44:50Z-
dc.date.issued2018es_ES
dc.identifier.citationCedeño Cueva, Julio Alejandro. (2018). Tiempo de duplicación del PSA como factor pronóstico para recaída o progresión en pacientes con cáncer de próstata tratados con radioterapia en el Instituto de cáncer SOLCA Loja, en los años 2009, 2010, 2011, 2012 en un seguimiento a 5 años. (Trabajo de Titulación de Medico ). UTPL, Loja.es_ES
dc.identifier.other1284044es_ES
dc.identifier.urihttp://dspace.utpl.edu.ec/handle/20.500.11962/22920-
dc.descriptionAbstract:The main objective of the present project was to determine whether PSA doubling after treatment with radiotherapy, by reviewing medical records, is a reliable predictor of local relapse or disease progression in patients with prostate cancer at the Institute of Cancer SOLCA Loja, during 2009, 2010, 2011, 2012 for routine use of these and for their comparison with existing literature. For this, a search was made in the database of the health establishment to the patients with this pathology to be able to perform the registration of the PSA follow-up before and after the treatment. The results obtained in the present study show that the initial PSA more frequently was in the range of >20n g / dL; the Gleason score 7, the clinical stage IV, high risk group, were all treated with radiotherapy, 34 patients 15 had local relapse and 13 disease progression at 5 years, which can be corroborated by established criteria for both local relapse and disease progression. Finally, it was concluded that PSA doubling time serves as a prognostic factor for local relapse and disease progression.es_ES
dc.language.isospaes_ES
dc.subjectCáncer.es_ES
dc.subjectSolca - Loja.es_ES
dc.subjectMédico -Tesis y disertaciones académicases_ES
dc.titleTiempo de duplicación del PSA como factor pronóstico para recaída o progresión en pacientes con cáncer de próstata tratados con radioterapia en el Instituto de cáncer SOLCA Loja, en los años 2009, 2010, 2011, 2012 en un seguimiento a 5 añoses_ES
dc.typebachelorThesises_ES
Appears in Collections:Médico

Files in This Item:
File SizeFormat 
Cedeño Cueva Julio Alejandro.pdf1.31 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.